The Costa Rican Social Security System (CCSS) will temporarily suspend the use of hydroxychloroquine and lopinavir-ritonavir as treatments for COVID-19 patients.
Costa Rican health authorities said Monday that the country will reevaluate its strategy of using hydroxychloroquine to treat coronavirus patients after the World Health Organization (WHO) suspended clinical trials of the drug.
Dozens of U.S. citizens filled the Augusto Sandino airport in Managua to leave the country, a day after health authorities reported a sharp increase in infections.
